Cargando…
Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches
Parkinson's disease (PD) is the most common neurodegenerative movement disorder in the elderly. As the pathogenesis of PD is still not fully understood, medications with the capacity of halting the disease progression are currently unavailable. The discovery of genes that are causative for, or...
Autores principales: | Huang, Yue, Wei, Jun, Cooper, Antony, Morris, Margaret J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308076/ https://www.ncbi.nlm.nih.gov/pubmed/37396535 http://dx.doi.org/10.1016/j.gendis.2021.12.015 |
Ejemplares similares
-
Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease
por: He, Ting, et al.
Publicado: (2023) -
Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
por: Prasuhn, Jannik, et al.
Publicado: (2021) -
αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?
por: Protter, David, et al.
Publicado: (2012) -
From the Gut to the Brain and Back: Therapeutic Approaches for the Treatment of Network Dysfunction in Parkinson's Disease
por: Paolone, Giovanna
Publicado: (2020) -
Genetics provides new individualized therapeutic targets for Parkinson’s disease
por: Garcia, Eric Joshua, et al.
Publicado: (2020)